Philip Morris (PM) AI Stock Analysis

• Market Cap: $276.98B
• Dividend Yield: 3.59%
• Average Volume (3M): 5.34M
• Price to Earnings (P/E): 21.0
• Beta (1Y): -0.13
• Revenue Growth: 7.72%
• EPS Growth: -12.45%
• Country: US
• Employees: 83,100
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Tobacco
• EPS (TTM): 1.70
• Shares Outstanding: 1,556,679,600
• 10 Day Avg. Volume: 4,678,695
• 30 Day Avg. Volume: 5,340,341
• PEG Ratio: 0.32
• Price to Book (P/B): -24.14
• Price to Sales (P/S): 5.94
• P/FCF Ratio: 22.63
• Enterprise Value/Market Cap: 1.11
• Enterprise Value/Revenue: 7.59
• Enterprise Value/Gross Profit: 11.43
• Enterprise Value/Ebitda: 18.04
• 1Y Price Target: $197.86
• Price Target Upside: 10.51% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 11
• EPS Forecast (FY): 8.45
• Revenue Forecast (FY): $43.75B

• Rating: 72 Outperform
• Price Target: $199.00 ▲(11.15% Upside)
• Action: Reiterated Date: 03/05/26
• Date: Action: Reiterated 03/05/26

The score is driven primarily by strong profitability and cash-flow generation, reinforced by upbeat guidance and continued smoke-free growth momentum. Offsetting this, the balance sheet remains the largest risk (high leverage and persistently negative equity), while technicals are supportive longer term but show near-term weakness; valuation appears reasonable with a solid dividend yield.

Positive Factors

High and expanding margins

Sustained high gross and operating margins driven by smoke-free mix create durable earnings power and strong operating leverage. Margin expansion supports free cash flow generation, funds reinvestment into smoke-free R&D/scale, and underpins consistent shareholder returns even if top-line growth slows.

Leading smoke-free revenue mix and scale

A large and growing smoke-free revenue base shifts the company’s structural growth profile away from combustibles. Broad geographic rollout, category share and millions of users create durable competitive advantages, improving pricing power, distribution reach, and R&D payback across multiple markets.

Consistent cash generation and capital return focus

Robust operating cash flow that recently strengthened and explicit deleveraging targets enable sustained dividends and strategic investment. Reliable cash conversion supports funding for expansion, productivity programs, and debt reduction without forcing near-term cuts to shareholder returns.

Negative Factors

Elevated leverage and negative shareholder equity

Persistent negative equity and elevated debt reduce financial flexibility and raise refinancing and rating risks. This structural capital-structure weakness constrains the firm's ability to absorb shocks, pursue aggressive acquisitions, or accelerate buybacks without materially increasing leverage risk.

Excise tax and regional regulatory headwinds

Material excise changes create structural demand pressure in key markets by increasing consumer prices and reducing affordability. Such tax-driven volume declines can persist for multiple years, compressing unit growth in affected regions and limiting the pace of smoke-free adoption and revenue diversification.

Execution risk from ZYN supply, inventory and regulatory timing

Channel inventory imbalances and supply constraints create volatile reported shipments and make sustainable US pouch growth contingent on regulatory approvals. Protracted normalization or regulatory delays could compress near-term revenue and margin trajectories and slow category share gains.

Philip Morris Business Overview & Revenue Model

Company Description

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

How the Company Makes Money

Philip Morris generates revenue primarily through the sale of its tobacco products, which include both traditional cigarettes and smoke-free alternatives like heated tobacco products and e-vapor products. The company's key revenue streams come from the global sale of these products, with a significant portion of earnings derived from its flagship brand, Marlboro. Additionally, Philip Morris has been investing heavily in research and development to innovate and expand its portfolio of reduced-risk products, which are increasingly becoming a focus as regulatory pressures on smoking increase. The company engages in significant marketing and distribution partnerships to enhance product reach and consumer engagement, contributing to overall sales. The ongoing transition towards smoke-free products is expected to play a crucial role in the company’s future revenue growth.

Philip Morris Financial Statement Overview

Summary

Operating performance is strong (high gross and EBIT margins and a rebound in net margin in 2025) and cash generation is consistently robust with improved free cash flow in 2025. The key offset is elevated financial risk from sizeable debt and persistently negative shareholder equity, which reduces balance-sheet flexibility despite durable earnings power.

Income Statement

Profitability is a clear strength: gross margin stayed high (~63%–68%) and operating profitability remained very strong (EBIT margin ~34%–41%) across 2020–2025. After a modest 2024 net margin (~19%), 2025 rebounded to a strong ~28% with net income rising meaningfully. Revenue growth has been positive in most years (brief dip in 2020), but the pace is uneven and the 2025 growth figure appears unusually high versus the underlying revenue trend, suggesting a less stable growth trajectory than the margin profile.

Balance Sheet

Leverage and capital structure are the key weak spots. Total debt is large and has generally trended higher since 2020, while shareholder equity is negative in every year shown (roughly -$9B to -$13B), which limits balance-sheet flexibility and makes equity-based leverage and return measures unfavorable. Asset growth is moderate, but the persistent negative equity profile elevates financial risk despite strong earnings power.

Cash Flow

Cash generation is consistently strong and supportive. Operating cash flow is healthy (roughly $9B–$12B annually) and free cash flow is robust, improving sharply in 2025 (with strong free-cash-flow growth). Cash conversion is solid, with free cash flow generally covering most of net income and reaching full coverage in 2025. The main watch-out is volatility in year-to-year free-cash-flow growth (declines in 2022–2023 before re-accelerating).

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	40.60B	37.88B	35.17B	31.76B	31.41B
Gross Profit	26.96B	24.55B	22.28B	20.36B	21.38B
EBITDA	17.08B	15.75B	13.37B	13.48B	13.97B
Net Income	11.50B	7.03B	7.79B	9.05B	9.11B
Balance Sheet
Total Assets	69.19B	61.78B	65.30B	61.68B	41.29B
Cash, Cash Equivalents and Short-Term Investments	4.87B	4.22B	3.06B	3.21B	4.50B
Total Debt	48.84B	45.70B	47.91B	43.12B	27.81B
Total Liabilities	77.21B	71.65B	74.75B	67.99B	49.50B
Stockholders Equity	-9.99B	-11.75B	-11.22B	-8.96B	-10.11B
Cash Flow
Free Cash Flow	10.66B	10.77B	7.88B	9.73B	11.22B
Operating Cash Flow	12.23B	12.22B	9.20B	10.80B	11.97B
Investing Cash Flow	-4.49B	-1.09B	-3.60B	-15.68B	-2.36B
Financing Cash Flow	-7.61B	-9.48B	-5.58B	3.81B	-11.98B

Philip Morris Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 179.04
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PM, the sentiment is Neutral. The current price of 179.04 is below the 20-day moving average (MA) of 184.24, above the 50-day MA of 173.85, and above the 200-day MA of 165.42, indicating a neutral trend. The MACD of 2.32 indicates Positive momentum. The RSI at 46.77 is Neutral, neither overbought nor oversold. The STOCH value of 22.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PM.

Philip Morris Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RLX	76 Outperform	$2.78B	29.81	4.71%	0.35%	51.49%	21.43%
PM	72 Outperform	$276.98B	20.98	―	3.59%	7.72%	-12.45%
BTI	69 Neutral	$131.25B	7.23	15.94%	5.22%	0.48%	―
MO	66 Neutral	$115.18B	13.92	―	7.02%	-0.96%	-11.42%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
TPB	59 Neutral	$2.06B	34.13	21.45%	0.28%	6.71%	8.16%
UVV	56 Neutral	$1.34B	9.94	5.81%	6.15%	3.01%	-7.14%

Philip Morris Corporate Events

Philip Morris Declares Quarterly Dividend Amid Smoke-Free Shift

On March 5, 2026, Philip Morris International Inc. announced that its board declared a regular quarterly dividend of $1.47 per common share, underscoring the group’s continued commitment to returning cash to shareholders. The dividend will be payable on April 13, 2026, to investors of record as of March 19, 2026, with the same date set as the ex-dividend date.

The move comes as Philip Morris advances its transition toward smoke-free products, which already account for a substantial share of its revenues and user base. Sustaining a robust dividend alongside heavy investment in reduced-risk and non-nicotine offerings highlights the company’s effort to balance shareholder returns with long-term portfolio transformation in the global nicotine and wellness markets.

The most recent analyst rating on (PM) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris Highlights Momentum in Smoke-Free Revenue Shift

On February 18, 2026, Philip Morris International used its appearance at the Consumer Analyst Group of New York Conference to showcase the scale and momentum of its transition toward smoke-free products, highlighting that annual smoke-free net revenues have reached about $17 billion across 106 markets and now account for roughly 42% of total net revenues. Management emphasized that several regions, especially Europe, are already majority smoke-free by net revenues, that overall shipment volumes have shifted from structural decline to low single-digit growth driven by smoke-free products, and that the wider cigarette industry outside China and the U.S. shows steeper declines in markets where smoke-free products are available, underscoring both PMI’s strategic repositioning and the growing regulatory and public-health acceptance of tobacco harm-reduction models centered on non-combustible nicotine options.

The most recent analyst rating on (PM) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris Reaffirms 2026 EPS Outlook and Growth

On February 18, 2026, Philip Morris International said its CEO Jacek Olczak and CFO Emmanuel Babeau would present at the Consumer Analyst Group of New York Conference, outlining how the transformed group is navigating an evolving operating environment and scaling its smoke-free brands. The company also highlighted its focus on shareholder value, including 2026–2028 growth targets, underlining its strategic push to consolidate leadership in next-generation nicotine products.

At the event, PMI reaffirmed its 2026 full-year reported diluted EPS forecast of $7.87 to $8.02 announced on February 6, with adjusted diluted EPS seen between $8.38 and $8.53, implying 11.1% to 13.1% growth versus $7.54 in 2025. Excluding a favorable $0.27 currency impact per share, the company projects adjusted EPS growth of 7.5% to 9.5%, signaling confidence in its earnings trajectory despite ongoing regulatory, litigation and macroeconomic risks flagged in its cautionary statements.

The most recent analyst rating on (PM) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris boosts U.S. smoke-free investments and jobs

On January 15, 2026, Philip Morris International and its U.S. businesses disclosed that since 2022 they have deployed more than $20 billion in U.S.-related investments, largely tied to the 2022 acquisition of Swedish Match and subsequent spending on domestic manufacturing, commercial rights, infrastructure and jobs, including more than $1 billion invested after the acquisition through September 30, 2025. The company highlighted new infrastructure projects in Colorado, Kentucky and North Carolina expected to create over 1,000 direct and 1,500 indirect jobs and deliver an estimated annual economic impact exceeding $800 million, alongside more than $35 million in charitable contributions since 2022—nearly $12 million of which went to about 600 nonprofits in 47 states and Washington, D.C. in 2025 alone. PMI U.S. underscored its role as a U.S. leader in “modern nicotine” and smoke-free products such as ZYN and IQOS, noting that PMI affiliates hold a dominant share of FDA modified-risk and premarket tobacco product marketing authorizations, and that its U.S. workforce has grown from several hundred to over 3,000 employees as it seeks to accelerate the shift of America’s roughly 30 million adult smokers to science-based, smoke-free alternatives.

The most recent analyst rating on (PM) stock is a Buy with a $185.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris Announces Quarterly Dividend Payment

On December 12, 2025, Philip Morris International announced a regular quarterly dividend of $1.47 per common share, payable on January 14, 2026. This decision reflects the company’s ongoing commitment to returning value to its shareholders while continuing its strategic shift towards smoke-free products. The announcement underscores PMI’s strong financial position and its dedication to evolving its business model to include products outside of the traditional tobacco and nicotine sectors.

The most recent analyst rating on (PM) stock is a Hold with a $160.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Philip Morris Enters New $2 Billion Credit Agreement

On December 11, 2025, Philip Morris International Inc. entered into a new credit agreement effective January 29, 2026, for a $2.0 billion revolving credit facility with Citibank Europe plc and Citibank, N.A. This facility, which will be used for general corporate purposes, replaces an existing facility set to expire in 2027. Additionally, PMI amended and extended a €1.5 billion credit facility, pushing its expiration to January 29, 2029. These financial maneuvers aim to enhance PMI’s liquidity and operational flexibility, potentially impacting its financial stability and stakeholder relations.

The most recent analyst rating on (PM) stock is a Hold with a $156.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.